MHC
CC icon

Meyer Handelman Company’s Chemours CC Stock Holding History

Meyer Handelman Company’s Portfolio CC Stock Details CC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-31,709
Closed -$261K – 185
2016
Q2 		$261K Sell
31,709
-6,578
-17% -$58.6K 0.01% 178
2016
Q1 		$268K Sell
38,287
-2,570
-6% -$12.9K 0.01% 188
2015
Q4 		$219K Sell
40,857
-18,297
-31% -$117K 0.01% 197
2015
Q3 		$383K Buy
+59,154
New +$619K 0.02% 166

Other funds holding CC

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
GC
GMT Capital Atlanta, Georgia $1.92B AUM 70.51% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GCM
Gates Capital Management New York $4.16B AUM 21% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Meyer Handelman Company's CC Position: Q3 2016 in Review

Meyer Handelman Company sold out of Chemours (CC) in Q3 2016, closing a stake of 31,709 shares — an estimated $261K sold.

Meyer Handelman Company first reported a position in CC in Q3 2015 and held it in 4 quarters. The position peaked at $383K in Q3 2015. 379 funds tracked by Wall St. Rank hold CC as of Q3 2016.

  • Meyer Handelman Company reported no remaining Chemours position as of Q3 2016 after selling out during the quarter.
  • Meyer Handelman Company sold 31,709 Chemours shares in Q3 2016, an estimated $261K.
  • Meyer Handelman Company first reported a position in Chemours in Q3 2015 and held it in 4 quarters.
  • Meyer Handelman Company's Chemours position peaked at $383K in Q3 2015.
  • 379 funds tracked by Wall St. Rank held Chemours as of Q3 2016.

Based on Meyer Handelman Company's 13F filing for Q3 2016, filed 3 Nov 2016.